Mosaic ImmunoEngineering Statistics
Total Valuation
Mosaic ImmunoEngineering has a market cap or net worth of 4.42 million. The enterprise value is 5.86 million.
| Market Cap | 4.42M |
| Enterprise Value | 5.86M |
Important Dates
The last earnings date was Friday, November 1, 2024.
| Earnings Date | Nov 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Mosaic ImmunoEngineering has 7.24 million shares outstanding. The number of shares has increased by 0.00% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 7.24M |
| Shares Change (YoY) | +0.00% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 88.69% |
| Owned by Institutions (%) | 0.00% |
| Float | 818,872 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.50 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01
| Current Ratio | 0.01 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.97 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -386.02% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -177,416 |
| Employee Count | 8 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +99.60% in the last 52 weeks. The beta is -1.71, so Mosaic ImmunoEngineering's price volatility has been lower than the market average.
| Beta (5Y) | -1.71 |
| 52-Week Price Change | +99.60% |
| 50-Day Moving Average | 0.91 |
| 200-Day Moving Average | 0.66 |
| Relative Strength Index (RSI) | 28.86 |
| Average Volume (20 Days) | 207 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.01M |
| Pretax Income | -1.06M |
| Net Income | -1.06M |
| EBITDA | n/a |
| EBIT | -1.01M |
| Earnings Per Share (EPS) | -0.15 |
Balance Sheet
The company has 5,736 in cash and 1.45 million in debt, giving a net cash position of -1.44 million or -0.20 per share.
| Cash & Cash Equivalents | 5,736 |
| Total Debt | 1.45M |
| Net Cash | -1.44M |
| Net Cash Per Share | -0.20 |
| Equity (Book Value) | -6.64M |
| Book Value Per Share | -0.92 |
| Working Capital | -5.26M |
Cash Flow
| Operating Cash Flow | -317,162 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Mosaic ImmunoEngineering does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.00% |
| Shareholder Yield | -0.00% |
| Earnings Yield | -24.59% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on December 2, 2020. It was a reverse split with a ratio of 0.002.
| Last Split Date | Dec 2, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.002 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |